Cormorant Asset Management’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,300,000
| Closed | -$18.3M | – | 50 |
|
|
2024
Q1 | $18.3M | Buy |
+1,300,000
| New | +$18.3M | 0.8% | 35 |
|
|
2023
Q3 | – | Sell |
-1,000,000
| Closed | -$8.33M | – | 52 |
|
|
2023
Q2 | $8.33M | Hold |
1,000,000
| – | – | 0.47% | 41 |
|
|
2023
Q1 | $13.3M | Sell |
1,000,000
-650,000
| -39% | -$8.65M | 0.88% | 32 |
|
|
2022
Q4 | $24.6M | Buy |
1,650,000
+450,000
| +38% | +$6.7M | 1.64% | 21 |
|
|
2022
Q3 | $10.8M | Buy |
1,200,000
+900,000
| +300% | +$8.14M | 0.76% | 39 |
|
|
2022
Q2 | $900K | Hold |
300,000
| – | – | 0.07% | 74 |
|
|
2022
Q1 | $2.01M | Sell |
300,000
-252,903
| -46% | -$1.7M | 0.15% | 66 |
|
|
2021
Q4 | $2.98M | Hold |
552,903
| – | – | 0.18% | 66 |
|
|
2021
Q3 | $4.89M | Sell |
552,903
-38,764
| -7% | -$343K | 0.2% | 69 |
|
|
2021
Q2 | $7.49M | Buy |
+591,667
| New | +$7.49M | 0.25% | 66 |
|
|
2017
Q1 | – | Sell |
-13,333
| Closed | -$2.89M | – | 76 |
|
|
2016
Q4 | $2.89M | Hold |
13,333
| – | – | 0.39% | 52 |
|
|
2016
Q3 | $4.93M | Buy |
+13,333
| New | +$4.93M | 0.54% | 51 |
|